Trials / Conditions / Deaf Blind
Deaf Blind
4 registered clinical trials studyying Deaf Blind — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Study to Evaluate Ultevursen in Subjects With Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH NCT06627179 | Laboratoires Thea | Phase 2 |
| Terminated | Study to Evaluate the Efficacy Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon NCT05176717 | Laboratoires Thea | Phase 2 / Phase 3 |
| Terminated | Study to Evaluate the Efficacy Safety and Tolerability of Ultevursen in Subjects With RP Due to Mutations in E NCT05158296 | Laboratoires Thea | Phase 2 / Phase 3 |
| Completed | Study to Evaluate Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the US NCT03780257 | ProQR Therapeutics | Phase 1 / Phase 2 |